UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Estimating meaningful change thresholds for Skin Pain‐Numeric Rating Scale, Sleep‐Numeric Rating Scale and Dermatology Life Quality Index in patients with prurigo nodularis

Journal of the European Academy of Dermatology and Venereology, 2024-07, Vol.38 (7), p.1401-1409

2024

Volltextzugriff (PDF)

Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial

Journal of asthma and allergy, 2023-01, Vol.16, p.323-332

2023

Volltextzugriff (PDF)

Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes - a study in both people with type 2 diabetes and healthy subjects

Diabetes, obesity & metabolism, 2014-09, Vol.16 (9), p.793-800

2014

Volltextzugriff (PDF)

S295: CLINICAL RELEVANCE OF SPLEEN VOLUME AND PLATELET COUNT WITH BLEEDING EVENTS IN PATIENTS WITH ACID SPHINGOMYELINASE DEFICIENCY (ASMD)

HemaSphere, 2022-06, Vol.6, p.196-197

2022

Volltextzugriff (PDF)

Comparaison indirecte du dupilumab et du tezepelumab chez des patients atteints d’asthme sévère

Revue des maladies respiratoires actualités, 2023-01, Vol.15 (1), p.65-66

2023

Volltextzugriff (PDF)

Efficacité et sécurité du dupilumab chez des patients adultes atteints de dermatite atopique modérée à sévère ayant des antécédents d’utilisation d’immunosuppresseur : analyse post-hoc de l’étude de phase 3 CAFÉ

Annales de dermatologie et de vénéréologie, 2019-12, Vol.146 (12), p.A341-A342

2019

Volltextzugriff (PDF)

P1532: SUTIMLIMAB AFTER PRIOR RITUXIMAB USE IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): POOLED POST‐HOC ANALYSES FROM THE CARDINAL AND CADENZA TRIALS

HemaSphere, 2022-06, Vol.6 (Suppl), p.1413-1414

2022

Volltextzugriff (PDF)

PCR87 Supporting Diversity and Inclusion Through the Evaluation of Differential Item Functioning (DIF) By Race and Ethnicity in the Asthma Control Questionnaire and Asthma Quality of Life Questionnaire Using Dupilumab Phase 3 Data

Value in health, 2024-06, Vol.27 (6), p.S311-S312

2024

Volltextzugriff (PDF)

MSR120 A Method for Adjusting US Health State Utilities for Use in the UK

Value in health, 2023-12, Vol.26 (12), p.S416

2023

Volltextzugriff (PDF)

Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2021-06, Vol.9 (6), p.2461-2471.e5

2021

Volltextzugriff (PDF)

Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps

International forum of allergy & rhinology, 2021-07, Vol.11 (7), p.1087-1101

2021

Volltextzugriff (PDF)

CO76 Switching Therapy from Alglucosidase Alfa to Avalglucosidase Alfa in Patients with Late Onset Pompe Disease (LOPD): Longitudinal Assessment of Respiratory Function from the Comet Trial

Value in health, 2023-06, Vol.26 (6), p.S28-S28

2023

Volltextzugriff (PDF)

PCR122 Psychometric Evaluation of Multiple Sclerosis Impact Scale 29 Version 2 in Relapsing Multiple Sclerosis Patients Participating in a Phase 2 Study of Frexalimab

Value in health, 2023-12, Vol.26 (12), p.S472

2023

Volltextzugriff (PDF)

PCR66 Psychometric Validation of PROMIS-Fatigue-MS-8a Questionnaire in Relapsing Multiple Sclerosis Patients Participating in a Phase 2 Study of Frexalimab

Value in health, 2023-12, Vol.26 (12), p.S461

2023

Volltextzugriff (PDF)

PCR10 Psychometric Evaluation and Estimation of Meaningful Change Thresholds of Patient-Reported Outcome Measures in Chronic Inducible Cold Urticaria

Value in health, 2024-06, Vol.27 (6), p.S296-S296

2024

Volltextzugriff (PDF)

Symptom Free Days In Patients With Severe Chronic Rhinosinusitis with Nasal Polyps Treated with Dupilumab

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022-02, Vol.149 (2), p.AB143-AB143

2022

Volltextzugriff (PDF)

CO32 Validation of a Scoring Algorithm for the Clinician-Reported Outcome ”Prurigo Activity and Severity (PAS)’’ Tool: Results Based on Clinical Studies of Dupilumab in Adults with Prurigo Nodularis

Value in health, 2023-12, Vol.26 (12), p.S20

2023

Volltextzugriff (PDF)

A longitudinal observational study of a cohort of patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate

European journal of neurology, 2007-11, Vol.14 (11), p.1266-1274

2007

Volltextzugriff (PDF)

CO168 Defining Clinically Meaningful Thresholds (CMT) for Forced Vital Capacity (FVC) and Six-Minute Walk Test (6MWT) in Patients with Late-Onset Pompe Disease (LOPD)

Value in health, 2023-06, Vol.26 (6), p.S46-S46

2023

Volltextzugriff (PDF)

POMPE DISEASE

Neuromuscular disorders : NMD, 2021-10, Vol.31, p.S111

2021

Volltextzugriff (PDF)

POMPE DISEASE: EP.203 Mobility, usual activities and EQ-5D visual analogue score improvement with avalglucosidase alfa in Late-onset Pompe disease during the COMET trial

Neuromuscular disorders : NMD, 2021-10, Vol.31, p.S111-S111

2021

Volltextzugriff (PDF)

S135 Dupilumab efficacy vs standard of care in patients with uncontrolled, persistent asthma – a meta analysis

Thorax, 2021-02, Vol.76 (Suppl 1), p.A81-A81

2021

Volltextzugriff (PDF)

P38 Dupilumab Improves Quality of Life in Caregivers of Children with Uncontrolled Moderate-to-Severe Asthma: Liberty Asthma Voyage Study

Value in health, 2022-07, Vol.25 (7), p.S294-S295

2022

Volltextzugriff (PDF)

PCR70 Avalglucosidase Alfa (AVA) Improves Symptoms and Functioning in Late-Onset Pompe Disease (LOPD) Patients vs Alglucosidase Alfa (ALG): Post-Hoc Analyses of Patient-Reported Outcomes (PROs) From COMET Trial

Value in health, 2022-12, Vol.25 (12), p.S403-S403

2022

Volltextzugriff (PDF)

Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study

Journal of asthma and allergy, 2022-06, Vol.15, p.767-773

2022

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(41)

Sprache

Englisch
(39)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Estimating meaningful change thresholds for Skin Pain‐Numeric Rating Scale, Sleep‐Numeric Rating Scale and Dermatology Life Quality Index in patients with prurigo nodularis

Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial

Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes - a study in both people with type 2 diabetes and healthy subjects

S295: CLINICAL RELEVANCE OF SPLEEN VOLUME AND PLATELET COUNT WITH BLEEDING EVENTS IN PATIENTS WITH ACID SPHINGOMYELINASE DEFICIENCY (ASMD)

Comparaison indirecte du dupilumab et du tezepelumab chez des patients atteints d’asthme sévère

Efficacité et sécurité du dupilumab chez des patients adultes atteints de dermatite atopique modérée à sévère ayant des antécédents d’utilisation d’immunosuppresseur : analyse post-hoc de l’étude de phase 3 CAFÉ

P1532: SUTIMLIMAB AFTER PRIOR RITUXIMAB USE IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): POOLED POST‐HOC ANALYSES FROM THE CARDINAL AND CADENZA TRIALS

PCR87 Supporting Diversity and Inclusion Through the Evaluation of Differential Item Functioning (DIF) By Race and Ethnicity in the Asthma Control Questionnaire and Asthma Quality of Life Questionnaire Using Dupilumab Phase 3 Data

MSR120 A Method for Adjusting US Health State Utilities for Use in the UK

Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps

Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps

CO76 Switching Therapy from Alglucosidase Alfa to Avalglucosidase Alfa in Patients with Late Onset Pompe Disease (LOPD): Longitudinal Assessment of Respiratory Function from the Comet Trial

PCR122 Psychometric Evaluation of Multiple Sclerosis Impact Scale 29 Version 2 in Relapsing Multiple Sclerosis Patients Participating in a Phase 2 Study of Frexalimab

PCR66 Psychometric Validation of PROMIS-Fatigue-MS-8a Questionnaire in Relapsing Multiple Sclerosis Patients Participating in a Phase 2 Study of Frexalimab

PCR10 Psychometric Evaluation and Estimation of Meaningful Change Thresholds of Patient-Reported Outcome Measures in Chronic Inducible Cold Urticaria

Symptom Free Days In Patients With Severe Chronic Rhinosinusitis with Nasal Polyps Treated with Dupilumab

CO32 Validation of a Scoring Algorithm for the Clinician-Reported Outcome ”Prurigo Activity and Severity (PAS)’’ Tool: Results Based on Clinical Studies of Dupilumab in Adults with Prurigo Nodularis

A longitudinal observational study of a cohort of patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate

CO168 Defining Clinically Meaningful Thresholds (CMT) for Forced Vital Capacity (FVC) and Six-Minute Walk Test (6MWT) in Patients with Late-Onset Pompe Disease (LOPD)

POMPE DISEASE

POMPE DISEASE: EP.203 Mobility, usual activities and EQ-5D visual analogue score improvement with avalglucosidase alfa in Late-onset Pompe disease during the COMET trial

S135 Dupilumab efficacy vs standard of care in patients with uncontrolled, persistent asthma – a meta analysis

P38 Dupilumab Improves Quality of Life in Caregivers of Children with Uncontrolled Moderate-to-Severe Asthma: Liberty Asthma Voyage Study

PCR70 Avalglucosidase Alfa (AVA) Improves Symptoms and Functioning in Late-Onset Pompe Disease (LOPD) Patients vs Alglucosidase Alfa (ALG): Post-Hoc Analyses of Patient-Reported Outcomes (PROs) From COMET Trial

Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study

Suchergebnisse filtern